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Abstract
Background: Low milk supply is a common cause of early weaning, and supply issues are associated with
dysregulation of thyroid function and prolactin. However, hormone levels compatible with successful breast-
feeding are not well defined, limiting interpretation of clinical lab results. In this study we sought to quantify
ranges for thyroid-stimulating hormone (TSH), free thyroxine (T4), total T4, and prolactin in a cohort of
exclusively breastfeeding women.
Materials and Methods: Women planning to breastfeed were recruited in the third trimester of pregnancy.
Maternal endocrine function was assessed before and after a breastfeeding session at 2 and 8 weeks postpartum.
We used paired t tests to determine whether values changed from the 2- to 8-week visit.
Results: Of 52 study participants, 28 were exclusively breastfeeding, defined as only breastmilk feeds in the
prior 7 days, at both the 2- and 8-week study visits. Endocrine function changed with time since delivery:
the TSH level was higher, whereas total T4, free T4, and prolactin levels were lower, at the 8-week visit than at
the 2-week visit (by paired t test, p £ 0.01). We found a wide range of prolactin values at the 8-week visit, with a
5th percentile value of 9 ng/dL before feeding and 74 ng/dL at 10 minutes after feeding.
Conclusions: Neuroendocrine function changes during the first 8 weeks after birth, and a wide range of values
is compatible with successful breastfeeding. Further studies are needed to define reference values in breast-
feeding women.
Introduction
Breastfeeding is a major determinant of health out-comes for mothers and infants. For parous women, not
breastfeeding is associated with an increased risk of diabetes,
hypertension, heart disease, and breast and ovarian cancer.1
For infants, not being breastfed is linked with acute condi-
tions such as otitis media and gastroenteritis, as well as in-
creased risks of obesity, type 1 diabetes, and sudden infant
death syndrome.2 Thus, all major medical organizations
recommend 6 months of exclusive breastfeeding, followed
by continued breastfeeding through the child’s first birthday
or longer, as mutually desired by mother and infant.3
Although a growing proportion of women initiate breast-
feeding in the United States, only 18.8% achieve the re-
commended 6 months of exclusive breastfeeding.4 Maternal
report of low milk supply is one of the most common reasons
for formula supplementation, cited by 51.7% of women who
discontinue breastfeeding in the first month postpartum.5
Low milk supply may reflect preglandular, grandular, or
postglandular problems,6 and evaluation requires assessment
of maternal endocrine function, breast anatomy, and infant
latch and feeding patterns.
Endocrine evaluation may include assessment of thyroid
function and prolactin levels. Thyroid disorders have been
associated with low milk supply,7–10 and circulating triio-
dothyronine (T3) and thyroxine (T4) are correlated with milk
production.11 Cross-sectional studies have found differences
in thyroid functioning between lactating and nonlactating
women,12 but normal ranges for maternal thyroid-stimulating
hormone (TSH), T4, and free T4 in exclusively breastfeeding
women are not defined. Prolactin stimulates milk synthesis,
and a low prolactin level has been implicated in etiology of
low milk supply, but data are limited. Most longitudinal
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studies of prolactin were performed more than 20 years ago
using assays that are not currently in use.13–15 Furthermore,
although the ratio of postfeeding to basal prolactin has been
proposed as an index of endocrine function, normal ranges
for this parameter have not been defined. Evidence also
suggests that normal values change with time postpartum. A
recent longitudinal study of prolactin levels in mothers of
term versus preterm infants found that basal and poststimu-
lation levels of prolactin decrease over time for both groups,
reflecting the transition from endocrine to autocrine control
of milk synthesis.16 Currently, there are no reference values
for normal prolactin and thyroid hormone levels in lactat-
ing women, limiting interpretation of clinical measures in
women experiencing breastfeeding difficulties.
To address this gap, we measured TSH, T4, free T4, and
prolactin levels in a cohort of women who were breastfeeding
exclusively at 2 and 8 weeks postpartum. We defined ex-
clusive breastfeeding as the infant receiving only breastmilk
for the 7 days prior to assessment to identify a cohort of
women with sufficient milk production to meet the infant’s
needs. We hypothesized that ranges would differ from 2 to 8
weeks postpartum, reflecting both changes in steroid binding
globulin and transition from endocrine to autocrine control of
milk synthesis.
Materials and Methods
We performed a secondary analysis of women enrolled in a
longitudinal study of maternal mood and infant feeding that
has been described in detail elsewhere.17 Women who
planned to breastfeed were enrolled from February 2010 to
2011 during the third trimester of pregnancy. Mothers re-
turned with their infants at 1–2 and 6–8 weeks after birth for
an observed feeding session. We restricted the current anal-
ysis to women who were exclusively breastfeeding, defined
as no formula or other supplementation in the prior 7 days, at
both the 1–2- and 6–8-week visit because this population of
women was producing enough milk to meet infant demand.
Our definition of exclusive breastfeeding included infants
who were fed at the breast or fed mother’s expressed milk via
a bottle during the week prior to the study visit.
Study visit procedure
Participants presented at the University of North Carolina at
Chapel Hill Mother-Infant Biobehavioral Lab for the observed
feeding sessions at 2 and 8 weeks postpartum. All lab visits
occurred in the early afternoon, which coincides with the nadir
for TSH levels.18 An antecubital intravenous line was placed to
allow collection of multiple blood draws during a feeding
session. After a 10-minute habituation period and 10 minutes
of baseline rest, a blood sample was obtained, and each woman
was asked to feed her infant as she usually would. A second
blood sample was obtained at minute 10 of feeding, and a third
sample was obtained 10 minutes after feeding was completed.
Data collection
At enrollment during pregnancy, participants were assessed
by a board-certified psychiatrist with extensive training in
administration of structured research interviews (S.M.-B.)
using the depression and anxiety disorder modules of the
Structured Clinical Interview Non-Patient version.19 Breast-
feeding intensity was assessed at 2 and 8 weeks postpartum
with a 1-week infant feeding recall and was defined as the
percentage of all milk feedings that were breastmilk.20 Mo-
thers were asked to report how many times in the last day they
had fed their infant breastmilk, formula, or other foods. If they
had not fed the food in the past day, they were asked how many
times they had fed the food in the past week. We excluded
from our analysis dyads with any infant intake other than
breastmilk in the 7 days prior to the study visit.
We assessed current mood at each visit using validated
instruments for assessment of mood and anxiety: the Edin-
burgh Postnatal Depression Scale (EPDS)21,22 and the State
and Trait Anxiety Inventories (STAI) of Spielberger.23 Par-
ticipants also reported any medications that they were taking.
We excluded from the current analysis women who were
taking galactogogues.
Neuroendocrine hormone assessment
Each venous blood sample was collected into prechilled
Vacutainer tubes (BD, Franklin Lakes, NJ), immediately
cold-centrifuged, aliquoted into prechilled cryotubes, and
stored at - 80C for later endocrine assays. We used com-
mercial radioimmunoassays (MP Biomedicals, Orangeburg,
NY) to measure TSH (recovery, 94%; inter-assay coefficient
of variation [CV], 5.4%; intra-assay CV, 4.3%), T4 (recovery,
96%; inter-assay CV, 5.3%; intra-assay CV, 4.3%), free T4
(recovery, 93%; inter-assay CV, 7.4%; intra-assay CV, 3.8%),
and prolactin (recovery, 103.1%; inter-assay CV, 8.2%; intra-
assay CV, 4.8%).
Analysis
We calculated mean, standard deviation, median, and 5%
and 95% values for TSH, free T4, total T4, and prolactin levels
at both the 2- and 8-week visits. We similarly reported median,
5%, and 95% values for postfeeding to basal prolactin ratio.
We further present spaghetti plots of prolactin trajectory for
study participants at both the 2- and 8-week visits to illustrate
the range of values seen in our study population (Fig. 1).
To determine whether thyroid function and prolactin levels
changed from 2 to 8 weeks postpartum, we used paired t tests.
We further used unpaired t tests, Wilcoxon rank-sum tests, or
Spearman correlation, as appropriate, to determine whether
maternal characteristics, including parity (nulliparous versus
multiparous), age (less than median versus greater than or
equal to median), and depression/anxiety history (ever versus
never, determined by standardized clinical interview), higher
anxiety symptoms (STAI state ‡ 34 [with 34 being the me-
dian for women of reproductive age]), or current antide-
pressant use, were associated with differences in hormone
levels. The small number of women with EPDS scores above
the minor depression threshold ( > 9) precluded comparisons
on this basis (n = 4 at 2 weeks, n = 2 at 8 weeks). We used
Pearson correlations to test whether duration of the lab visit
feeding episode or number of feedings per day was associated
with hormone levels.
Results
We recruited 52 women during the third trimester. Of
these, 48 attended the 2-week postpartum visit, among whom
33 were exclusively breastfeeding at the breast. Of these 33
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women, 29 were still exclusively breastfeeding at the 8-week
visit. One woman pumped during the study visits and was
therefore excluded. The 28 women who were feeding their
infants only breastmilk, either expressed or at the breast, in
the preceding week and who fed at the breast at both study
visits made up our sample.
Our study population was predominantly white, and the
majority had completed college or postgraduate education
(Table 1). By design of the parent study, almost half of the
study participants had a history of depression or anxiety. At
both visits, 10 women (35.7%) had scores on the STAI state
inventory of ‡34. At 2 weeks postpartum, five women were
taking antidepressants, of whom four had STAI state scores
of ‡34 and one had an EPDS score of >9. At 8 weeks, six
women were taking antidepressants, of whom five had STAI
scores of ‡34 and two had EPDS scores of >9. All six wo-
men taking antidepressants had a current or lifetime history
of anxiety or depression based on prenatally administered
Structured Clinical Interview Non-Patient version. Of these
six women, one was taking medication during pregnancy and
at both postpartum visits, two initiated medication between
the enrollment visit and the 2-week visit, and one initiated
therapy between the 2- and 8-week visit.
Women presented for study visits at a median of 14 and 48
days postpartum. We found significant changes in observed
neuroendocrine markers from the 2-week to the 8-week visit
for all measured markers (Table 2). Free T4, total T4, and
prolactin levels all declined within individual women be-
tween the 2- and 8-week visit (by paired t test, p < 0.01 for all
comparisons), whereas the TSH level increased between the
2- and 8-week visit (by paired t test, p = 0.004). We found no
association between parity, mood history, anxiety symptoms,
maternal age, or current antidepressant use and TSH, T4, free
T4, or prolactin values at any time point in our study sample
(all p > .05).
A wide range of prolactin trajectories was observed among
exclusively breastfeeding women at study visits (Fig. 1 and
Table 2). The 5th percentile for baseline prolactin among our 28
women was 32 ng/mL at 2 weeks and 9 ng/mL at 8 weeks. Ten
minutes after feeding, the 5th percentile for prolactin was 57 ng/
mL at 2 weeks and 74 ng/mL at 8 weeks. When we calculated
the ratio of prolactin measured at 10 minutes after feeding to the
prefeeding prolactin, the median was 1.50 (5–95%, 1.17–8.37)
at 2 weeks and 2.31 (5–95%, 1.05–7.40) at 8 weeks. Post-
feeding:prefeeding prolactin ratios were similar within women
from the 2- to 8-week visit (by paired t test, p = 0.61).
The duration of the observed feeding varied among the
participants in our study at both 2 weeks (median, 15 minutes;
95% confidence interval, 6–27) and 8 weeks (median, 13
FIG. 1. Prolactin trajectories for 28 exclusively breast-
feeding mothers at 2 and 8 weeks postpartum. Color images
available online at www.liebertpub.com/bfm
Table 1. Study Population
Demographic Value
Age (years) [mean (SD)] 32.1 (4.1)
Race [n (%)]
White 26 (92.9)
Black or African American 2 (7.1)
Education [n (%)]
< 4-year college graduate 3 (10.7)
Graduated 4-year college 9 (32.1)
Postgraduate 16 (57.1)
BMI (kg/m2) [n (%)]
< 25 9 (32.1)
25 to < 30 11 (39.3)
‡ 30 8 (28.6)
Income [n (%)]
Less than $40,000 4 (14.8)
$40,000–59,999 4 (14.8)
$60,000–99,999 8 (29.6)




Mode of delivery [n (%)]
Spontaneous vaginal birth 20 (83.3)
Vacuum 2 (8.3)
Cesarean section 2 (8.3)
Depression or anxiety [n (%)]
History
Never 15 (53.6)
Lifetime, not current 8 (28.6)
Current 5 (17.9)
Taking antidepressants
2 weeks postpartum 5 (17.9)
8 weeks postpartum 6 (21.4)
Higher anxietya
2 weeks postpartum 10 (35.7)
8 weeks postpartum 10 (35.7)
aState and Trait Anxiety Inventories state of ‡ 34, with 34 being
the median for women of reproductive age.
BMI, body mass index; SD, standard deviation.
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minutes; 95% confidence interval, 6–25). At 2 weeks, we
found a correlation between feeding duration and baseline
TSH level (Pearson’s r = 0.49, p = 0.02) and with prolactin
levels 10 minutes after feeding (Pearson’s r = 0.47, p = 0.02).
We found no association between number of feedings per day
and any endocrine measure at 2 weeks. At 8 weeks, feeding
duration was correlated with prolactin levels 10 minutes after
feeding (r = 0.46, p = 0.02). Prolactin physiology varied by
number of feedings per day (Fig. 2). More frequent feedings
were associated with higher baseline prolactin, although the
correlation was not statistically significant ( p = 0.12) (Fig.
2A). Number of feedings per day was inversely associated
with change in prolactin level from baseline to 10 minutes
after feeding (r = –0.57, p = 0.002) (Fig. 2D).
Discussion
In a sample of exclusively breastfeeding women, we found
that both thyroid and prolactin values changed from 2 to 8
weeks postpartum. These results suggest that reference ran-
ges specific for lactating women at discrete postpartum in-
tervals may be needed to interpret endocrine assessment in
the postpartum period. We further found that a wide range of
prolactin values was compatible with exclusive breastfeeding
and that the ratio of postfeeding:baseline prolactin levels
varied with feeding frequency. These results provide a con-
text in which to interpret thyroid and prolactin levels among
women experiencing milk production difficulties.
Ours is the first study to our knowledge to report within-
subject changes in thyroid physiology in breastfeeding
women in the early postpartum period. Kurioka et al.24 measured
thyroid function during pregnancy and at 3–4 days postpar-
tum and found lower free T4 and higher TSH than during
pregnancy. Ekinci et al.25 conducted a longitudinal study of
thyroid function in each trimester and at 8–12 weeks post-
partum and found that free T4 and free T3 levels decreased
in the second and third trimester and were similar to first
trimester values at 8–12 weeks postpartum, but the propor-
tion of breastfeeding participants was not described. Iwatani
et al.12 measured thyroid function in a cross-sectional study
of lactating and nonlactating woman at 3 months postpartum
and nonpregnant controls and found that lactating women had
lower free T4 and reverse T3 levels than nonlactating post-
partum women as well as a higher thyroid-binding globulin
level than nonpregnant controls. The authors concluded that
thyroid hormone functioning is markedly different in lactat-
ing women. We found that total and free T4 values fall sig-
nificantly from 2 to 8 weeks postpartum in breastfeeding
women. These results may inform decisions regarding thy-
roid replacement dose in the early postpartum period.
Our work confirms and extends earlier work on normal
ranges for prolactin during lactation. Several studies from the
1970s and 1980s measured prolactin levels over time, al-
though these studies used assays no longer in clinical use.
These authors reported a wide range of values associated with
adequate milk production and further found that baseline and
peak levels fall with time since birth, although the ratio of
peak to baseline remained constant.13–15
The wide range of prolactin levels in our study and prior
literature suggest that other factors, including lactocyte up-
take of circulating prolactin,26 may determine milk produc-
tion. Indeed, Cox et al.27 found no association between
circulating prolactin and short-term milk synthesis rate or 24-
hour milk production. These authors suggest that prolactin
plays a permissive role in milk synthesis but that prolactin
levels do not determine supply. If prolactin levels do not
affect production, then agents such as domperidone and
metoclopramide would not be expected to increase milk
production among women with prolactin levels in the
’‘‘normal’’ range. Given concerns about side effects from
these agents,28 future studies should explore whether baseline
prolactin levels predict response to treatment.
We found that change in prolactin levels from baseline to
10 minutes after feeding was inversely correlated with
Table 2. Neuroendocrine Markers at 2 and 8 Weeks Postpartum Among Exclusively
Breastfeeding Mothers
2 weeks 8 weeks pa Referenceb
Days postpartum 13 (8–18) 48 (43–55)
Breastfeedings per day 9 (8–12) 8 (6–11) < 0.001
Observed feeding duration (minutes) 15 (6–27) 13 (6–25) 0.62
TSH (mIU/L) 0.34–4.25
Baseline 0.90 (0.45–1.91) 1.19 (0.64–1.75) 0.004
Free T4 (ng/dL) 0.7–1.24
Baseline 0.97 (0.79–1.32) 0.90 (0.67–1.18) < 0.001
10 minutes after feeding 0.96 (0.78–1.19) 0.90 (0.66–1.13) 0.007
Total T4 (lg/dL) 5.4–11.7
Baseline 9.02 (6.60–12.28) 6.42 (5.76–8.12) < 0.001
10 minutes after feeding 9.15 (6.21–11.16) 6.49 (5.77–7.75) < 0.001
Prolactin (ng/mL) 1.9–25
Baseline 124 (32–277) 68 (9–184) < 0.001
Minute 10 153 (45–308) 102 (20–216) < 0.001
10 minutes after feeding 270 (57–533) 177 (74–393) < 0.001
Ratio 10 minutes after feeding: Baseline 1.50 (1.17–8.37) 2.31 (1.05–7.40) 0.61
Data are median (5–95%) values.
aBy paired t test, 2 versus 8 weeks.
bFrom Harrison’s Online > Appendix: Laboratory Values of Clinical Importance (www.accessmedicine.com [accessed October 5, 2012]).
T4, thyroxine; TSH, thyroid-stimulating hormone.
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feeding frequency at 8 weeks. This association may reflect
higher baseline prolactin values among women who feed
more frequently or may result from a need to feed more
frequently to allow adequate milk transfer in the setting of
lower prolactin response. In either case, our results suggest
that the normal range for ratio of postfeeding:baseline pro-
lactin levels may vary, depending on feeding frequency. The
wide variations that we observed in our sample, as well as the
lack of evidence for an association between prolactin and
milk production, suggest that clinically useful reference
values for prolactin during lactation may not exist.
Our findings must be interpreted in the context of the study
design. Our study population was largely white, highly edu-
cated, and oversampled for women with a history of de-
pression or anxiety. Thus our results may not be generalizable
to other populations. However, we did not detect an associ-
ation between maternal mood history, state anxiety, or anti-
depressant use and endocrine values, suggesting that
inclusion of these participants did not bias our results. The
timing of our sample collection is an important limitation.
Noel et al.29 found that the prolactin level peaks 40 minutes
after the baby is put to the breast. We sampled prolactin at
baseline, 10 minutes of feeding, and 10 minutes after feeding,
and differences in the time from initiation of feeding to
sample collection may have increased the variability in our
results. Moreover, prior work suggests that one-third of
women achieve peak prolactin levels at 1 hour or more after
feeding,14 so it is possible that we underestimated peak
postfeeding prolactin levels. However, in clinical practice,
multiple samples are not practical, whereas a sample col-
lected 10 minutes after feeding is feasible to achieve. In ad-
dition, we did not measure milk transferred during feeding
in our study, limiting our ability to interpret associations
between feeding frequency and endocrine profiles.
Conclusions
We found significant changes in prolactin and thyroid
profiles among exclusively breastfeeding women during the
first 8 weeks postpartum. We further found that a wide range
of prolactin levels was compatible with exclusive breast-
feeding. Our results underscore the need for longitudinal
research to define reference values for prolactin and thyroid
levels in the postpartum period. These studies should also
evaluate the clinical utility of checking prolactin levels in
mothers with low milk supply. Such work will provide
FIG. 2. Correlation between number of breastfeedings per day and prolactin levels at (A) baseline, (B) 10 minutes after
starting feeding, and (C) 10 minutes after the end of feeding and (D) the ratio of postfeeding:baseline prolactin levels among
28 exclusively breastfeeding women at 8 weeks postpartum.
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evidence to improve clinical evaluation and management of
women with milk supply concerns.
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